SAB Biotherapeutics Inc (SABS) — Long-term Investment Intensity
SAB Biotherapeutics Inc (SABS) has a Long-term Investment Intensity of 27.1% as of December 2025. Long-term investments of $46.89 Million represent 27.1% of total assets of $172.81 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See SAB Biotherapeutics Inc net assets for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
SAB Biotherapeutics Inc Long-term Investment Intensity (2025–2025)
This chart shows how SAB Biotherapeutics Inc's Long-term Investment Intensity has evolved across 1 annual periods from 2025 to 2025. As of December 2025, the intensity stands at 27.1%, reflecting long-term investments of $46.89 Million against total assets of $172.81 Million USD. Also explore SAB Biotherapeutics Inc (SABS) total assets for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for SAB Biotherapeutics Inc (2025–2025)
The table below presents the year-by-year Long-term Investment Intensity for SAB Biotherapeutics Inc from 2025 to 2025, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see market cap of SAB Biotherapeutics Inc.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 27.1% | $46.89 Million | $172.81 Million | — |